feed,title,long_url,short_url
SeekingAlpha,Immix stock climbs 40% on in-licensing potential blood cancer therapy,https://seekingalpha.com/news/3916920,
SeekingAlpha,Mersana Therapeutics gets European orphan drug designation for ovarian cancer treatment,https://seekingalpha.com/news/3916921,
